Health

LINEPHARMA INTERNATIONAL FILES FOR MANUFACTURING, MARKETING APPROVAL OF THE ABORTION PILL IN JAPAN

Linepharma International Ltd., a global leader in medical abortion, announced today that its subsidiary Linepharma KK has applied for manufacturing and marketing approval in Japan for its oral drug MEFEEGO™ for the medical termination of pregnancies of up to 63 days of gestation. The medication is recognized as the international gold standard for first trimester medical […]

thaipr.net

23 ธ.ค. 64

Karyopharm and Menarini Group Enter into Exclusive License Agreement to Commercialize NEXPOVIO® (selinexor) in Europe and Other Key Global Territories

– Menarini Group Obtains Exclusive Rights to Commercialize NEXPOVIO for the Treatment of Hematologic and Solid Tumor Oncology Indications in Europe (including the United Kingdom), Latin America and Other Key Countries – Karyopharm to Receive $75 Million Upfront, then Eligible to Receive Up to $202.5 Million in Future Milestones, Plus Tiered, Double-digit Royalties on Net […]

thaipr.net

23 ธ.ค. 64

Technology central to sustainability, affordability of global healthcare industry

Artificial Intelligence & Machine learning drive better health outcomes and affordability Healthcare spending saw a steep decline during the COVID-19 pandemic with associated lockdowns, restrictions, and postponement of non-essential treatments. However, the trend is expected to be short-lived as COVID-19 vaccines and testing became widely available, and healthcare usage begins to rebound. “Almost every year, and with […]

thaipr.net

22 ธ.ค. 64

2021 Sustainability Report of Sai Life Sciences highlights the momentum gained in its Sustainability choices

– Report developed as per Global Reporting Initiative (GRI) standards– Extensively deals with the company’s response to the Covid-19 pandemic Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO/ CDMO), today announced the release of its 2021 Sustainability Report. Developed as per the Global Reporting Initiative (GRI) standards, the report highlights the momentum […]

thaipr.net

22 ธ.ค. 64

World Health Organization SAGE Issues Interim Recommendations for Novavax COVID-19 Vaccine

– WHO Strategic Advisory Group of Experts on Immunization (SAGE) recommends primary two-dose vaccination series of NVX-CoV2373 in persons aged 18 and older – SAGE recommends additional third dose of NVX-CoV2373 administered to immunocompromised persons – Recommendation follows grant of WHO Emergency Use Listing for Novavax’ vaccine Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and…

thaipr.net

22 ธ.ค. 64

EVERSANA completes acquisition of Intouch Group, adds the premiere digital-first agency network to the market leader in next generation commercialization

EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, today announced it has completed its acquisition of Intouch Group®, a full-service global agency network serving the pharmaceutical industry. The acquisition immediately propels EVERSANA’s position as a $1 billion commercial services leader with more than 40 locations and 5,500 employees worldwide, poised to […]

thaipr.net

22 ธ.ค. 64

CSTONE ANNOUNCED NEW DRUG APPROVAL OF CEJEMLY® (SUGEMALIMAB) IN CHINA TO POTENTIALLY RESHAPE THE LANDSCAPE OF IMMUNO-ONCOLOGY THERAPY IN LUNG CANCER

CStone Pharmaceuticals (the “Company” or “CStone“) is pleased to announce that the National Medical Products Administration (“NMPA“) of China has approved the new drug application (“NDA“) of anti-PD-L1 monoclonal antibody Cejemly® (sugemalimab) in combination with chemotherapy for treatment-naïve metastatic (stage IV) non-small cell lung cancer (“non-small cell lung caner” or…

thaipr.net

21 ธ.ค. 64

World Health Organization Grants Second Emergency Use Listing for Novavax COVID-19 Vaccine

– Nuvaxovid™ COVID-19 Vaccine (SARS-CoV-2 rS [Recombinant, adjuvanted]) listed for emergency use by the WHO – EUL for Nuvaxovid complements listing for Novavax vaccine manufactured and marketed by Serum Institute of India as Covovax™ – EUL by WHO is a prerequisite for exports to numerous countries participating in the COVAX Facility Novavax, Inc. (Nasdaq: NVAX), a biotechnology company […]

thaipr.net

21 ธ.ค. 64

European Commission Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine

Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) is the first protein-based COVID-19 vaccine authorized for use in Europe Novavax and the European Commission previously announced an advance purchase agreement for up to 200 million doses through 2023 Authorization follows positive recommendation by European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) Novavax, Inc. (Nasdaq: NVAX), […]

thaipr.net

21 ธ.ค. 64
1 … 89 90 91 92 93 … 133

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.